HPV-associated oropharyngeal cancer

被引:14
|
作者
Sheedy, Trina [1 ]
Heaton, Chase [1 ]
机构
[1] Univ Calif San Francisco, Med Ctr, Dept Otolaryngol Head & Neck Surg, San Francisco, CA 94115 USA
关键词
human papillomavirus; HPV; vaccine; oropharyngeal squamous cell carcinoma; physician assistant; HUMAN-PAPILLOMAVIRUS; NECK-CANCER; UNITED-STATES; HEAD; VACCINATION; PREVALENCE; INFECTIONS; KNOWLEDGE;
D O I
10.1097/01.JAA.0000578756.52642.cb
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Exposure of the oral cavity and oropharynx to human papillomavirus (HPV) often results in an asymptomatic, transient oral infection that is cleared by the body's immune system; however, a small percentage of these oral infections can persist in a dormant state. Depending on the HPV genotype, a persistent oral infection may lead to benign or malignant disease. High-risk HPV types 16 and 18, which cause most cervical and anal cancers, also are the cause of the rising rate of oropharyngeal squamous cell carcinoma (SCC) in the United States. This article focuses on the epidemiology, transmission, risk factors, and clinical presentation of HPV-associated oropharyngeal SCC, and provides an update on HPV vaccination in the context of the new head and neck cancer epidemic.
引用
收藏
页码:26 / 31
页数:6
相关论文
共 50 条
  • [1] Epidemiology of HPV-associated oropharyngeal cancer
    Pytynia, Kristen B.
    Dahlstrom, Kristina R.
    Sturgis, Erich M.
    [J]. ORAL ONCOLOGY, 2014, 50 (05) : 380 - 386
  • [2] Distinguishing between HPV-Associated Metastatic Anal Squamous Cell Cancer and HPV-Associated Oropharyngeal Cancer
    Sorscher, Steven
    [J]. CASE REPORTS IN PATHOLOGY, 2020, 2020
  • [3] Early detection of HPV-associated oropharyngeal cancer Reply
    Graham, Donna
    Prue, Gillian
    Baker, Peter
    Nutting, Chris
    Greenhouse, Peter
    Lawler, Mark
    [J]. LANCET, 2019, 393 (10186): : 2123 - 2124
  • [4] Reply to 'HPV-associated oropharyngeal cancer - discussion points'
    Lechner, Matt
    Liu, Jacklyn
    Masterson, Liam
    Fenton, Tim R.
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2022, 19 (06) : 422 - 423
  • [5] Radiation Treatment Deintensification for HPV-Associated Oropharyngeal Cancer
    Dagan, Roi
    Galloway, Thomas J.
    [J]. SEMINARS IN RADIATION ONCOLOGY, 2021, 31 (04) : 324 - 331
  • [6] Serum Micrornas As Biomarkers Of HPV-Associated Oropharyngeal Cancer
    Tomasik, B.
    Papis-Ubych, A.
    Kedzierawski, P.
    Bibik, R.
    Latusek, T.
    Stando, R.
    Kowalik, A.
    Sadowski, J.
    Graczyk, L.
    Mazurek, A.
    Snietura, M.
    Rutkowski, T.
    Fijuth, J.
    Widlak, P.
    Fendler, W.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E793 - E794
  • [7] Reply to ‘HPV-associated oropharyngeal cancer — discussion points’
    Matt Lechner
    Jacklyn Liu
    Liam Masterson
    Tim R. Fenton
    [J]. Nature Reviews Clinical Oncology, 2022, 19 : 422 - 423
  • [8] Pathology of the HPV-associated Oropharyngeal Carcinoma
    Fukumura, Yuki
    [J]. CURRENT CANCER THERAPY REVIEWS, 2015, 11 (01) : 3 - 6
  • [9] Clinical, morphologic and molecular heterogeneity of HPV-associated oropharyngeal cancer
    Yvonne X. Lim
    Michelle L. Mierzwa
    Maureen A. Sartor
    Nisha J. D’Silva
    [J]. Oncogene, 2023, 42 : 2939 - 2955
  • [10] Clinical, morphologic and molecular heterogeneity of HPV-associated oropharyngeal cancer
    Lim, Yvonne X.
    Mierzwa, Michelle L.
    Sartor, Maureen A.
    D'Silva, Nisha J.
    [J]. ONCOGENE, 2023, 42 (40) : 2939 - 2955